21 min. Read
10.09.20

Five pharma companies talk digital therapeutic partnerships, DTx pricing, and more

At the recent (virtual, of course) DTx East event, which is typically held in Cambridge, MA, five pharma executives discussed the current state of digital therapeutics. This was probably the best panel at the event and it covered a range of important topics:

  • How far along pharma companies view digital therapeutics
  • Advice for approaching pharma companies for collabs
  • When do pharma companies build

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Mahana Therapeutics’ insolvency. FDA clears Happy Ring (Tinder founder’s smart ring)
10.04.24
6 min. Read
Flashback: How Proteus Digital Health’s outcomes-based pricing worked for Tennessee Medicaid
9.20.24
5 min. Read
Are the Digital Mental Health Treatment G Codes necessary? Or RTM dupes?
7.12.24
7 min. Read
Which PDTs are still around? New bill in Congress.
6.28.24
10 min. Read
FDA OKs Alivecor (12L?), Akili OTC. Oui eyes obesity.
6.21.24
5 min. Read
Digging into the Akili-Virtual Therapeutics deal
5.31.24
10 min. Read
CMS questions MedRhythms on InTandem
5.17.24
5 min. Read
MedRhythms-Alexion. Akili RCT for OTC.
4.26.24
6 min. Read
Hints about Otsuka’s commercialization plan for Rejoyn
4.16.24
6 min. Read
Better Therapeutics shuts down. Mahana-Cara Care
3.15.24
5 min. Read
  • First
  • Previous
  • 1 of 21
  • Next
  • Last